Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suprazygomatic Maxillary Nerve Block for Cleft Palate Surgery in Children
NCT04023825Withdrawn
- Sponsor
- CHU Amiens-Picardie
- Start
- Jul 2019
- Primary completion
- Jul 2022
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial of levobupivacaine in cleft palate (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Change from baseline of morphine consumption at 48 hours. Planned start Jul 2019; status: withdrawn.
02
Drugs
levobupivacaine
03
Conditions
cleft palate
Beyond the preview
Go deeper on NCT04023825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04023825.